Anzeige
Meldung des Tages: Das ist kein Gold-Boom, das ist ein Systembruch – und er hat gerade erst begonnen

CAC 40 Index

Index
WKN:  969400 ISIN:  FR0003500008
8.096,14
-0,34%
-27,3904
15:48:22 Uhr
Depot/Watchlist
Weiter abwärts? Short handeln - Jetzt mit Hebel 6,33: MG3CSP
Werbung

Ad-hocs

13.02.25 - GlobeNewswire
Press Release: Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report Paris, February 13, 2025 . Sanofi announces today the ...
13.02.25 - GlobeNewswire
Press Release: Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study
Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study Independent interim analysis of the E.mbrace phase 3 study finds that the vaccine candidate didn’t ...
07.02.25 - GlobeNewswire
Press Release: Execution of a share buyback agreement for up to €2 billion
Execution of a share buyback agreement for up to €2 billion Paris, February 7, 2025. On January 30, 2025 , Sanofi announced its intention to execute a share buyback program in ...
06.02.25 - GlobeNewswire
2024 Annual Results
Solid +5.1% Growth in a Challenging Context
06.02.25 - GlobeNewswire
ArcelorMittal S.A.: ArcelorMittal reports fourth quarter 2024 and full year 2024 results
Luxembourg, February 6 , 20 25 - ArcelorMittal (referred to as “ArcelorMittal” or the “Company” or the "Group") (MT (New York, Amsterdam, Paris, Luxembourg), MTS (Madrid)), the world’s ...
04.02.25 - GlobeNewswire
Publicis Groupe : Full Year 2024 Results
Full Year 2024 Results
03.02.25 - GlobeNewswire
Agreement Between L’Oréal and Sanofi for the Repurchase by Sanofi of 2.3% of Its Own Shares Held by L’Oréal
AGREEMENT BETWEEN L’ORÉAL AND SANOFI FOR THE REPURCHASE BY SANOFI OF 2.3% OF ITS OWN SHARES HELD BY L’ORÉAL
03.02.25 - GlobeNewswire
Press Release: Sanofi announces buy back of shares from L’Oréal
Sanofi announces buy back of shares from L’Oréal
31.01.25 - GlobeNewswire
Press Release: Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant
Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant
30.01.25 - GlobeNewswire
Press Release: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025
Sanofi: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025
28.01.25 - GlobeNewswire
ArcelorMittal announces the publication of its fourth quarter and full year 2024 sell-side analyst consensus figures 
ArcelorMittal (‘the Company’) today announces the publication of its fourth quarter and full year 2024 sell-side analyst consensus figures.
27.01.25 - EQS
EQS-Adhoc: Airbus reports share buyback transactions 20-24 January 2025
EQS-​Ad-hoc: Airbus SE / Key word(s): Share Buyback Airbus reports share buyback transactions 20-24 January 2025 27-Jan-2025 / 18:00 CET/CEST Disclosure of an inside ...
22.01.25 - GlobeNewswire
Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma
Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-​of-care VRd to treat transplant-​ineligible newly diagnosed multiple myeloma Approval is ...
21.01.25 - GlobeNewswire
Press Release: Opella reaches study milestone for Cialis
Opella reaches study milestone for Cialis
20.01.25 - EQS
EQS-Adhoc: Airbus reports share buyback transactions 13-17 January 2025
EQS-​Ad-hoc: Airbus SE / Key word(s): Share Buyback Airbus reports share buyback transactions 13-17 January 2025 20-Jan-2025 / 17:45 CET/CEST Disclosure of an inside ...
13.01.25 - EQS
EQS-Adhoc: Airbus reports share buyback transactions 3-10 January 2025
EQS-​Ad-hoc: Airbus SE / Key word(s): Share Buyback Airbus reports share buyback transactions 3-10 January 2025 13-Jan-2025 / 17:45 CET/CEST Disclosure of an inside ...
13.01.25 - GlobeNewswire
Press Release: Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma
Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma
09.01.25 - GlobeNewswire
Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma
New Sarclisa subcutaneous formulation met co-​primary endpoints in the IRAKLIA phase 3 study in multiple myeloma Sarclisa SC formulation added to Pd for the treatment of R/R ...
03.01.25 - EQS
EQS-Adhoc: Airbus reports share buybacks 23 Dec 2024 to 2 Jan 2025
EQS-​Ad-hoc: Airbus SE / Key word(s): Share Buyback Airbus reports share buybacks 23 Dec 2024 to 2 Jan 2025 03-Jan-2025 / 17:45 CET/CEST Disclosure of an inside information ...
23.12.24 - EQS
EQS-Adhoc: Airbus reports share buyback transactions 16-20 December 2024
EQS-​Ad-hoc: Airbus SE / Key word(s): Share Buyback Airbus reports share buyback transactions 16-20 December 2024 23-Dec-2024 / 17:45 CET/CEST Disclosure of an inside ...

Newssuche

Videos

newspaper
16.12.25 -0,05%
Technical Trading: DAX Setup mit Kurzfrist Trade
DAX Long Typ: Turbo Open End WKN: VK2CGA Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »